Don't Just Read the News, Understand It.
Get Started
SubscribeLogin
Eurovision
Baseball
Social Media
Natural Disasters
NCAA
Education
Instagram
Artificial Intelligence
Soccer
Donald Trump
Israel-Hamas Conflict
Published • loading... • Updated

Rein Therapeutics Announces Initiation of RENEW Phase 2 Trial of LTI-03 in Patients with IPF

Summary by Star Local
The RENEW Phase 2 trial will enroll up to 120 IPF patients with topline data expected in the first half of 2026
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All
Left
Center
Right
pharmatimes.compharmatimes.com

Rein Therapeutics initiates renew phase 2 trial for IPF treatment

Screening begins for study evaluating LTI-03 in idiopathic pulmonary fibrosi

Read Full Article
Star LocalStar Local

Rein Therapeutics Announces Initiation of RENEW Phase 2 Trial of LTI-03 in Patients with IPF

The RENEW Phase 2 trial will enroll up to 120 IPF patients with topline data expected in the first half of 2026

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Star Local broke the news in on Monday, May 12, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

News
For You
SearchBlindspotLocal